BERGENBIO ASABERGENBIO ASABERGENBIO ASA

BERGENBIO ASA

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪490.15 M‬NOK
−4.914NOK
‪−190.40 M‬NOK
‪354.00 K‬NOK
‪25.47 M‬
Beta (1Y)
0.36
Employees (FY)
16
Change (1Y)
−13 −44.83%
Revenue / Employee (1Y)
‪2.17 K‬NOK
Net income / Employee (1Y)
‪−1.17 M‬NOK

About BERGENBIO ASA


CEO
Olav Hellebø
Headquarters
Bergen
Founded
2007
ISIN
NO0013251173
FIGI
BBG00GF93S49
BerGenBio ASA engages in the development of biopharmaceutical product for cancer therapy. It focuses on developing a pipeline of AXL kinase inhibitors. Its lead product bemcentinib, is a selective and orally bio-available small molecule AXL inhibitor. The company was founded by James Bradley Lorens and David R. Micklem on December 21, 2007 and is headquartered in Bergen, Norway.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BGBIOO is 14.926 NOK — it has increased by ‪1.82 K‬% in the past 24 hours. Watch BERGENBIO ASA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange BERGENBIO ASA stocks are traded under the ticker BGBIOO.
BGBIOO stock has risen by ‪1.82 K‬% compared to the previous week, the month change is a ‪1.82 K‬% rise, over the last year BERGENBIO ASA has showed a ‪1.82 K‬% increase.
We've gathered analysts' opinions on BERGENBIO ASA future price: according to them, BGBIOO price has a max estimate of 38.00 NOK and a min estimate of 5.00 NOK. Watch BGBIOO chart and read a more detailed BERGENBIO ASA stock forecast: see what analysts think of BERGENBIO ASA and suggest that you do with its stocks.
BGBIOO reached its all-time high on May 18, 2020 with the price of 5.680 NOK, and its all-time low was 0.690 NOK and was reached on Sep 30, 2022. View more price dynamics on BGBIOO chart.
See other stocks reaching their highest and lowest prices.
BGBIOO stock is 95.79% volatile and has beta coefficient of 0.36. Track BERGENBIO ASA stock price on the chart and check out the list of the most volatile stocks — is BERGENBIO ASA there?
Today BERGENBIO ASA has the market capitalization of ‪461.23 M‬, it has increased by 82.44% over the last week.
Yes, you can track BERGENBIO ASA financials in yearly and quarterly reports right on TradingView.
BERGENBIO ASA is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
BGBIOO earnings for the last quarter are −0.63 NOK per share, whereas the estimation was −1.34 NOK resulting in a 52.99% surprise. The estimated earnings for the next quarter are −1.09 NOK per share. See more details about BERGENBIO ASA earnings.
BERGENBIO ASA revenue for the last quarter amounts to 0.00 NOK, matching the estimated figure, and no changes in revenue are expected for the next quarter.
BGBIOO net income for the last quarter is ‪−24.82 M‬ NOK, while the quarter before that showed ‪−49.72 M‬ NOK of net income which accounts for 50.09% change. Track more BERGENBIO ASA financial stats to get the full picture.
No, BGBIOO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 16.00 employees. See our rating of the largest employees — is BERGENBIO ASA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BERGENBIO ASA EBITDA is ‪−169.82 M‬ NOK, and current EBITDA margin is ‪−56.84 K‬%. See more stats in BERGENBIO ASA financial statements.
Like other stocks, BGBIOO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BERGENBIO ASA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BERGENBIO ASA technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BERGENBIO ASA stock shows the strong buy signal. See more of BERGENBIO ASA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.